Lexaria Signs Master Collaborative Research AgreementMaster Collaborative Research Agreement • March 29th, 2022
Contract Type FiledMarch 29th, 2022Lexaria believes that results from this scientific collaboration could motivate license adoption of Lexaria's patented flavour masking and nutrient delivery enhancement technology, including but not limited to the vitamin, pain reliever and nicotine sectors. Lexaria's technology is patented in the US, and patent pending in Canada and in 41 other countries around the world.